|
|
 |
|
Viewing report
|
|
|
|
Autism - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, Feb 2010, Pages: 30
Autism - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
“Autism - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global autism market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shaping and driving the global autism market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global autism sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
Scope
The scope of the report includes:
- Annualized global autism market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
- Pipeline analysis data, providing a split across different phases by mechanism of action being developed and emerging trends. Key classes of mechanism of action include 5-HT2A and D2 receptors antagonists, serotonin inhibitors, glutamate antagonists, antioxidants, cholinergic agents and immune response down regulators.
- Analysis of the current and future market competition in the global autism market. Key market players covered are Repligen Corporation, BioMarin Pharmaceuticals, and Neuropharm Group Plc.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for future market associated with autism.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global autism market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global autism market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global autism market landscape? - Identify, understand and capitalize.
Customers who bought this item also bought
Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights
Autism Spectrum Disorders - High Unmet Needs Create Significant Market Opportunities
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Migraine - Pipeline Assessment and Market Forecasts to 2016
Methicillin-Resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Trigeminal Neuralgia (TN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
|
|
|
|
